Erkrath, Germany

Andŕeas Knorr

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andŕeas Knorr. Retrieved from https://idiyas.com/inventor/andŕeas-knorr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andŕeas Knorr

Introduction

Andŕeas Knorr is a notable inventor based in Erkrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic use. His work focuses on creating innovative solutions for the treatment and prevention of diseases.

Latest Patents

One of Andŕeas Knorr's key patents is titled "Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof." This patent relates to novel substituted 1-benzylcycloalkylcarboxylic acid derivatives. It outlines processes for their preparation and their application in treating and preventing diseases, especially cardiovascular disorders. He holds 1 patent in this area.

Career Highlights

Andŕeas Knorr is associated with Bayer Intellectual Property GmbH, where he contributes to the advancement of pharmaceutical innovations. His expertise in medicinal chemistry has positioned him as a valuable asset in the research and development of new therapeutic agents.

Collaborations

Throughout his career, Andŕeas has collaborated with esteemed colleagues, including Thomas Lampe and Michael Hahn. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Andŕeas Knorr's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to medicinal chemistry continue to pave the way for advancements in disease treatment and prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…